{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:50:30Z","timestamp":1776981030438,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031365","name":"Oslo universitetssykehus HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016466","name":"State of New Jersey Division of Mental Health and Addiction Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016466","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020090"],"award-info":[{"award-number":["2020090"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2017025"],"award-info":[{"award-number":["2017025"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020088"],"award-info":[{"award-number":["2020088"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["MethodsX"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.mex.2024.102810","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T12:51:08Z","timestamp":1718801468000},"page":"102810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) \u2013 A pilot study protocol"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1070-0065","authenticated-orcid":false,"given":"Ingrid Amalia","family":"Havnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian Bordado","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Wiik","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Bj\u00f8rnebekk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudan Prasad","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonny","family":"Hisdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Wisl\u00f8ff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Lindvik","family":"J\u00f8rstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders Palmstr\u00f8m","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mex.2024.102810_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann. Epidemiol."},{"issue":"3","key":"10.1016\/j.mex.2024.102810_bib0002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MED.0000000000000404","article-title":"Public health impact of androgens","volume":"25","author":"Kanayama","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0003","first-page":"101","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes","volume":"13","author":"Piacentino","year":"2015","journal-title":"Syst. Rev."},{"issue":"3","key":"10.1016\/j.mex.2024.102810_bib0004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.mex.2024.102810_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/joim.12850","article-title":"Health consequences of androgenic anabolic steroid use","volume":"285","author":"Horwitz","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mex.2024.102810_bib0006","series-title":"Adverse Effects of Anabolic-Androgenic steroids: A literature review. in Healthcare","author":"Albano","year":"2021"},{"key":"10.1016\/j.mex.2024.102810_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1214374","article-title":"Anabolic androgenic steroids and cardiomyopathy: an update","volume":"10","author":"Fadah","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.mex.2024.102810_bib0008","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/diagnostics11081307","article-title":"Forensic post-mortem investigation in aas abusers: investigative diagnostic protocol. a systematic review","volume":"11","author":"Esposito","year":"2021","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.mex.2024.102810_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/HJH.0000000000001546","article-title":"Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?","volume":"36","author":"Rasmussen","year":"2018","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.mex.2024.102810_bib0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/eurjpc\/zwad362","article-title":"Severe biventricular cardiomyopathy in both current and former long-term users of anabolic\u2013androgenic steroids","volume":"31","author":"Abdullah","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"11","key":"10.1016\/j.mex.2024.102810_bib0011","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/medicina56110587","article-title":"Sudden cardiac death in anabolic-androgenic steroid users: a literature review","volume":"56","author":"Torrisi","year":"2020","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-14065-5","article-title":"Reduced arterial elasticity after anabolic\u2013androgenic steroid use in young adult males and mice","volume":"12","author":"Melsom","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mex.2024.102810_bib0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cen.13372","article-title":"Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids","volume":"87","author":"Rasmussen","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"10.1016\/j.mex.2024.102810_bib0014","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid\u2013induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0015","first-page":"43","article-title":"Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review","volume":"65","author":"Esposito","year":"2022","journal-title":"Panminerva Med."},{"issue":"6","key":"10.1016\/j.mex.2024.102810_bib0016","doi-asserted-by":"crossref","first-page":"10.1097","DOI":"10.1097\/MED.0000000000000822","article-title":"Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis","volume":"30","author":"Skauen","year":"2023","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"5","key":"10.1016\/j.mex.2024.102810_bib0017","doi-asserted-by":"crossref","first-page":"101691","DOI":"10.1016\/j.beem.2022.101691","article-title":"Common symptoms associated with usage and cessation of anabolic androgenic steroids in men","volume":"36","author":"Sharma","year":"2022","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.mex.2024.102810_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056445","article-title":"Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis","volume":"12","author":"Amaral","year":"2022","journal-title":"BMJ Open."},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0019","doi-asserted-by":"crossref","first-page":"e14554","DOI":"10.1111\/sms.14554","article-title":"Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: a cross-sectional study","volume":"34","author":"Henriksen","year":"2024","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.mex.2024.102810_bib0020","series-title":"Stigma and the Use of Anabolic Androgenic Steroids By Men in the United kingdom, in Drugs, Identity and Stigma","first-page":"121","author":"McVeigh","year":"2022"},{"issue":"4","key":"10.1016\/j.mex.2024.102810_bib0021","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/cen.14686","article-title":"Clinical question: how to manage symptoms of hypogonadism in patients after androgen abuse?","volume":"98","author":"Botman","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.mex.2024.102810_bib0022","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/JU.0000000000000396","article-title":"Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism","volume":"202","author":"Krzastek","year":"2019","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0023","first-page":"62","article-title":"Clomiphene citrate for male hypogonadism and infertility: an updated review","volume":"1","author":"Herzog","year":"2020","journal-title":"Androg. Clin. Res. Ther."},{"issue":"1","key":"10.1016\/j.mex.2024.102810_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13011-019-0206-5","article-title":"Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires","volume":"14","author":"Havnes","year":"2019","journal-title":"Subst. Abuse Treat. Prev. Policy."},{"issue":"8","key":"10.1016\/j.mex.2024.102810_bib0025","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/sms.14172","article-title":"Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes","volume":"32","author":"Fyksen","year":"2022","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"4","key":"10.1016\/j.mex.2024.102810_bib0026","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/humrep\/deaa366","article-title":"Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study","volume":"36","author":"Smit","year":"2021","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.mex.2024.102810_bib0027","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","article-title":"Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters","volume":"82","author":"Bj\u00f8rnebekk","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.mex.2024.102810_bib0028","doi-asserted-by":"crossref","first-page":"e3040","DOI":"10.1002\/brb3.3040","article-title":"Clustering psychopathology in male anabolic\u2013androgenic steroid users and nonusing weightlifters","volume":"13","author":"J\u00f8rstad","year":"2023","journal-title":"Brain Behav"},{"issue":"2","key":"10.1016\/j.mex.2024.102810_bib0029","first-page":"84","article-title":"The importance of piloting an RCT intervention","volume":"41","author":"Feeley","year":"2009","journal-title":"Can. J. Nurs. Res. Arch."},{"issue":"8","key":"10.1016\/j.mex.2024.102810_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"}],"container-title":["MethodsX"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016124002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016124002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:31:54Z","timestamp":1754321514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215016124002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"alternative-id":["S2215016124002632"],"URL":"https:\/\/doi.org\/10.1016\/j.mex.2024.102810","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3909247\/v1","asserted-by":"object"}]},"ISSN":["2215-0161"],"issn-type":[{"value":"2215-0161","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) \u2013 A pilot study protocol","name":"articletitle","label":"Article Title"},{"value":"MethodsX","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mex.2024.102810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102810"}}